Markets

  • First Stablecoin Public Listing Raises Concerns

    Circle (CRCL), a stablecoin issuer, debuted on the NYSE in June 2025 and surged 622% post-IPO, reaching a near $50 billion market cap. Stablecoins, likened to ADRs, face increasing regulatory scrutiny, exemplified by the “Clarity for Payment Stablecoins Act.” Circle’s USDC, positioned as a compliant alternative to USDT, saw fluctuating issuance and redemptions. Challenges include reliance on Coinbase, potential interest rate cuts impacting revenue, and competition from Big Tech and government initiatives. The US’s complex stance on stablecoins stems from SWIFT disruption and US debt demand dynamics.

    2025年7月21日
  • Nvidia’s Near-Death Experiences: Remembering the Two Close Calls

    Nvidia CEO Jensen Huang, despite the company’s $4 trillion market cap, feels constant pressure, stating Nvidia is “30 days from going out of business.” He attributes this to the rapid pace of technological obsolescence in the chip and AI industries. Nvidia faced near-bankruptcy twice: once due to the Dreamcast chipset failure and again from a graphics card design flaw leading to recalls. Huang’s commitment to innovation fuels his drive to guide Nvidia far into the future.

    2025年7月21日
  • Blackrock Silver Kicks Off Drill Program to Expand Eastern Trend at Tonopah West

    Blackrock Silver has commenced a fully-funded 5,000-meter expansion drill program at its Tonopah West project in Nevada. Following successful scout drilling, which extended the DPB South zone 1,200 meters eastward, the program will utilize three drill rigs across 15 holes. Scout drilling revealed high-grade mineralization, including 2,063 g/t silver equivalent over 1.52 meters. This newly defined zone, outside the 2024 resource, offers significant growth potential. Program completion is expected in October, with results incorporated into a Q1 2026 resource update.

    2025年7月21日
  • Xinjiang Embraces Free Shipping: Postal Chief Aims to Boost Nationwide Sales of Agricultural Products

    China’s express delivery volume has ranked first globally for 11 years, processing over 500 million parcels daily. In 2024, central and western China saw express delivery growth rates significantly above the national average, indicating successful strategic investments. The postal sector strengthens the modern circulation system and promotes balanced development. China is enhancing rural delivery logistics, aiming to bridge the urban-rural consumption gap. Xinjiang has achieved universal free e-commerce shipping, boosting agricultural product sales and improving rural residents’ access to online shopping. The sector’s growth also creates local employment opportunities.

    2025年7月21日
  • Close Call: US Passenger Plane Nearly Collides with B-52 Bomber

    On July 19th, a SkyWest Airlines Embraer E175LR, operating as Delta flight DL3788, narrowly avoided a mid-air collision with a B-52 bomber near Minot Air Force Base. Air traffic control instructed the plane to alter course, but the crew spotted the bomber approaching rapidly. An “abrupt turn” averted disaster. Passengers witnessed the near miss. The incident raises concerns about airspace management and coordination, prompting scrutiny of air safety protocols in increasingly congested airspace. The crew was commended for their quick thinking.

    2025年7月21日
  • User Publicly Apologizes for Smearing NIO and Disregarding Legal Department: Exploiting Sympathy

    A user publicly apologized to NIO after initially taunting their legal department over derogatory online comments. After being threatened with a lawsuit, the user claimed health issues and financial hardship, pleading for leniency and offering to remove the offensive content. He cited sleepless nights, exacerbated tinnitus, and weight loss due to the stress of the lawsuit and inability to afford cross-provincial litigation. He implored NIO to reduce the 1 million RMB claim, citing humanitarian considerations.

    2025年7月21日
  • Stellantis Releases Preliminary and Unaudited Key Figures for First Half 2025

    Stellantis reported preliminary unaudited H1 2025 results showing €74.3B net revenues but a €2.3B net loss and -€3.0B industrial free cash flow. Q2 global shipments declined 6% to 1.4M units. Results were impacted by €3.3B in charges for program cancellations, platform impairments, and restructuring, plus €0.3B from US tariffs. North American shipments fell 25%. Positive growth was seen in Middle East & Africa (30%) and South America (20%). The company anticipates improvement in H2 2025.

    2025年7月21日
  • 22-Year-Old Delivery Girl in Chongqing Loses 10 Pounds in 6 Days Climbing Stairs

    A 22-year-old woman in Chongqing, China, lost nearly ten pounds in six days by strategically choosing stair-climbing food delivery orders. This method, lauded online for its effectiveness, combines income generation with weight loss. Experts note stair climbing can be HIIT, improving cardiovascular health and muscle mass. However, due to knee joint stress, it’s not for everyone. Consulting a doctor or fitness professional for a personalized plan is recommended.

    2025年7月20日
  • IMO Slams OpenAI’s Self-Proclaimed Gold Medal as 91 Judges Deny Involvement: Critics Call It “Shameless PR”

    OpenAI’s claim of achieving an IMO gold medal with a new model has sparked controversy. IMO officials and academics criticize the premature announcement as “rude and inappropriate”, as it violates the agreed-upon embargo period. Concerns are raised regarding the legitimacy of OpenAI’s self-proclaimed gold medal, as it was not officially validated by IMO judges; OpenAI was not an official collaborator and their submission was not evaluated by the 91 IMO judges. China secured the top spot in the human competition, highlighting their dominance in the field.

    2025年7月20日
  • Genentech Updates on Astegolimab for COPD

    Genentech announced topline results from the Phase IIb ALIENTO and Phase III ARNASA trials evaluating astegolimab for COPD. ALIENTO met its primary endpoint, demonstrating a statistically significant reduction in the annualized exacerbation rate (AER) at 52 weeks. However, ARNASA did not meet its primary endpoint, despite a numerical reduction in AER. Astegolimab’s safety profile remained consistent with prior data. Genentech will discuss the data with regulatory authorities and present it at a future medical meeting. The trials included diverse COPD patients.

    2025年7月20日